Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 41

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 41
---
 sell securities in a public primary offering with a value
exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75,000,000. As of
the date of this prospectus, we have sold securities with an aggregate market value of $2,258,746 pursuant to General Instruction 1 .B.6
of Form S-3 during the 12-calendar month period that ends on and includes the date hereof.

INVESTING IN OUR SECURITIES INVOLVES RISKS.
YOU SHOULD REVIEW CAREFULLY THE RISKS AND UNCERTAINTIES DESCRIBED UNDER THE HEADING“RISK FACTORS” CONTAINED IN THE APPLICABLE PROSPECTUS SUPPLEMENT AND ANY RELATED FREE WRITING PROSPECTUS, AND UNDER SIMILAR HEADINGS IN OTHER DOCUMENTS THAT ARE INCORPORATED BY REFERENCE INTO THIS PROSPECTUS OR ANY SUCH PROSPECTUS SUPPLEMENT. SEE“RISK FACTORS”
ON PAGE 7 OF THIS PROSPECTUS.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus.
Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is April 3, 2024.

Table of Contents</div>

|                                                                                                 | Page |
| ABOUT THIS PROSPECTUS                                                                           |    1 |
| FORWARD-LOOKING STATEMENTS                                                                      |    2 |
| THE COMPANY                                                                                     |    4 |
| RISK FACTORS                                                                                    |    7 |
| USE OF PROCEEDS                                                                                 |    8 |
| DESCRIPTION OF SECURITIES WE MAY OFFER                                                          |    8 |
| DESCRIPTION OF COMMON STOCK WE MAY OFFER                                                        |    9 |
| DESCRIPTION OF PREFERRED STOCK WE MAY OFFER                                                     |   10 |
| DESCRIPTION OF DEBT SECURITIES WE MAY OFFER                                                     |   11 |
| DESCRIPTION OF WARRANTS WE MAY OFFER                                                            |   19 |
| DESCRIPTION OF UNITS WE MAY OFFER                                                               |   20 |
| CERTAIN PROVISIONS OF DELAWARE LAW AND OF THE COMPANY’S CERTIFICATE OF INCORPORATION AND BYLAWS |   21 |
| PLAN OF DISTRIBUTION                                                                            |   23 |
| LEGAL MATTERS                                                                                   |   25 |
| EXPERT